Results 141 to 150 of about 12,080 (321)

Sugammadex in pediatric patients

open access: yesAnesthesia and Pain Medicine, 2022
Jae Moon Choi, Hong Seuk Yang
openaire   +3 more sources

Evaluation of the effects of intra-arterial sugammadex and dexmedetomidine: an experimental study

open access: yesRevista Brasileira de Anestesiologia
Background: Intra-arterial injection of medications may cause acute and severe ischemia and result in morbidity and mortality. There is no information in the literature evaluating the arterial endothelial effects of sugammadex and dexmedetomidine.
Volkan Hancı   +9 more
doaj   +1 more source

Anaphylaxis to Sugammadex [PDF]

open access: yesAnaesthesia and Intensive Care, 2014
L. Savic   +2 more
openaire   +3 more sources

Sugammadex Versus Neostigmine In Reducing Postoperative Adverse Effects In The Pediatric Population [PDF]

open access: yes, 2020
Neostigmine and sugammadex are two medications used to reverse the neuromuscular blockade caused by nondepolarizing aminosteroidal neuromuscular blocking agents.
Vieto, Robert, Jr.
core   +1 more source

Sugammadex to reverse neuromuscular blockade in a child with a past history of cardiac transplantation

open access: yesAnnals of Cardiac Anaesthesia, 2017
Sugammadex is a novel agent for the reversal of neuromuscular blockade. The speed and efficacy of reversal with sugammadex are significantly faster than acetylcholinesterase inhibitors, such as neostigmine.
Karen Miller   +2 more
doaj   +1 more source

Dosage of sugammadex according to the calculated lean body mass in obese female patients: time to reverse moderate neuromuscular blockade induced by rocuronium [PDF]

open access: yes, 2019
Background: Sugammadex is a selective relaxant binding agent for antagonism of prolonged rocuronium-induced neuromuscular blockade. The recommended dose is 2 mg/kg.
Bougouma, Cheik Tidiane Hafid Wind-Pouiré   +1 more
core   +1 more source

CRNAs and Sugammadex Use: A Qualitative Analysis [PDF]

open access: yes, 2020
Background: The availability of Sugammadex has increased options for Certified Registered Nurse Anesthetists’ (CRNAs) and their choice of neuromuscular reversal agents, however administration is impacted by a variety of provider and institutional factors.
Izquierdo, Natalia, BSN, RN   +1 more
core   +1 more source

Home - About - Disclaimer - Privacy